INTERNATIONAL PATENT: IMMUNOGEN, INC., ZWEIDLER-MCKAY, PATRICK FILES APPLICATION FOR "TREATMENT OF UNFIT NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WITH PIVEKIMAB SUNIRINE, A BCL-2 INHIBITOR AND A HYPOMETHYLATING AGENT"

GENEVA, Nov. 19 -- IMMUNOGEN, INC. (1 N. Waukegan RoadNorth Chicago, Illinois 60064), ZWEIDLER-MCKAY, Patrick (c/o ImmunoGen, Inc.1 N. Waukegan RoadNorth Chicago, Illinois 60064) filed a patent application (PCT/US2025/028695) for "TREATMENT OF UNFIT NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WITH PIVEKIMAB SUNIRINE, A BCL-2 INHIBITOR, AND A HYPOMETHYLATING AGENT" on May 09, 2025. With publication no. WO/2025/235924, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): IMMUNOGEN, INC. (1 N. Waukegan RoadNorth Chicago, Illinois 6006...